You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 16, September 11, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Betaine Supplementation and Plasma Homocysteine in Healthy Volunteers

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Elevated plasma total homocysteine concentrations are considered a risk factor for giving birth to a child with a neural tube defect1-2 and for cardiovascular disease.3 Epidemiological studies suggest that elevated homocysteine concentrations are an independent and graded risk factor for vascular disease, with no apparent threshold.3-6 Therefore, it appears that a decrease in plasma total homocysteine concentration in the lower range is still relevant. Homocysteine can be transsulfurated to cysteine using vitamin B6 as a cofactor. It can also be remethylated to methionine. This reaction either uses 5-methyltetrahydrofolate as a substrate in a vitamin B12–dependent reaction or it uses betaine. In humans, the folate-dependent remethylation takes place in all cells, whereas the betaine-dependent remethylation reaction is mainly confined to the liver.7 Supplementation with folic acid has been shown to decrease total plasma homocysteine concentrations in healthy volunteers.8-9 As supplementation with betaine decreases plasma total homocysteine concentrations substantially in patients . . . [Full Text of this Article]

Subjects, Materials, and Methods


Results

Comment


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease: Not Validated
Kaul et al.
J Am Coll Cardiol 2006;48:914-923.
ABSTRACT | FULL TEXT  

Betaine and Folate Status as Cooperative Determinants of Plasma Homocysteine in Humans
Holm et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:379-385.
ABSTRACT | FULL TEXT  

Betaine in human nutrition
Craig
Am. J. Clin. Nutr. 2004;80:539-549.
ABSTRACT | FULL TEXT  

Betaine as a Determinant of Postmethionine Load Total Plasma Homocysteine Before and After B-Vitamin Supplementation
Holm et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:301-307.
ABSTRACT | FULL TEXT  

Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Refsum et al.
Clin. Chem. 2004;50:3-32.
ABSTRACT | FULL TEXT  

Low Dose Betaine Supplementation Leads to Immediate and Long Term Lowering of Plasma Homocysteine in Healthy Men and Women
Olthof et al.
J. Nutr. 2003;133:4135-4138.
ABSTRACT | FULL TEXT  

Betaine Supplementation Lowers Plasma Homocysteine in Healthy Men and Women
Steenge et al.
J. Nutr. 2003;133:1291-1295.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.